This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bozaoglu, K. Articles by Segal, D. Search for Related Content PubMed PubMed Citation Articles by Bozaoglu, K. Articles by Segal, D.

Chemerin Is a Novel Adipokine Associated with Obesity and Metabolic Syndrome

Metabolic Research Unit (K.Boz., K.Bol., J.M., K.W., D.S.), School of Exercise and Nutrition Sciences, Deakin University, Waurn Ponds, Geelong, Victoria 3217, Australia; International Diabetes Institute (P.Z., J.J.), Caulfield, Victoria 3162, Australia; and ChemGenex Pharmaceuticals (G.C., K.W.), Geelong, Victoria 3217, Australia

Address all correspondence and requests for reprints to: Dr. David Segal, Metabolic Research Unit, Deakin University, Pigdons Road, Waurn Ponds, Geelong, Victoria 3217, Australia. E-mail: dsegal{at}deakin.edu.au.

Soluble protein hormones are key regulators of a number of metabolic processes, including food intake and insulin sensitivity. We have used a signal sequence trap to identify genes that encode secreted or membrane-bound proteins in Psammomys obesus, an animal model of obesity and type 2 diabetes (T2D). Using this signal sequence trap, we identified the chemokine chemerin as being a novel adipokine. Gene expression of chemerin and its receptor, chemokine-like receptor 1 (CMKLR1), was significantly higher in adipose tissue of obese and type 2 diabetic P. obesus compared with lean, normoglycemic P. obesus. Fractionation of P. obesus adipose tissue confirmed that chemerin was predominantly expressed in adipocytes, whereas CMKLR1 was expressed in both adipocytes and stromal-vascular cells of adipose tissue. In 3T3-L1 adipocytes, chemerin was markedly induced during differentiation, whereas CMKLR1 was down-regulated during differentiation. Serum chemerin levels were measured by ELISA in human plasma samples from 114 subjects with T2D and 142 normal glucose tolerant controls. Plasma chemerin levels were not significantly different between subjects with T2D and normal controls. However, in normal glucose tolerant subjects, plasma chemerin levels were significantly associated with body mass index, circulating triglycerides, and blood pressure. Here we report, for the first time, that chemerin is an adipokine, and circulating levels of chemerin are associated with several key aspects of metabolic syndrome.

This article has been cited by other articles:

				S. Luangsay, V. Wittamer, B. Bondue, O. De Henau, L. Rouger, M. Brait, J.-D. Franssen, P. de Nadai, F. Huaux, and M. Parmentier Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model J. Immunol., November 15, 2009; 183(10): 6489 - 6499. [Abstract] [Full Text] [PDF]

				X.-Y. Du and L. L.K. Leung Proteolytic regulatory mechanism of chemerin bioactivity Acta Biochim Biophys Sin, November 12, 2009; (2009) gmp091v1. [Abstract] [Full Text] [PDF]

				C. Vernochet, S. B. Peres, K. E. Davis, M. E. McDonald, L. Qiang, H. Wang, P. E. Scherer, and S. R. Farmer C/EBP{alpha} and the Corepressors CtBP1 and CtBP2 Regulate Repression of Select Visceral White Adipose Genes during Induction of the Brown Phenotype in White Adipocytes by Peroxisome Proliferator-Activated Receptor {gamma} Agonists Mol. Cell. Biol., September 1, 2009; 29(17): 4714 - 4728. [Abstract] [Full Text] [PDF]

				B. K. Tan, J. Chen, S. Farhatullah, R. Adya, J. Kaur, D. Heutling, K. C. Lewandowski, J. P. O'Hare, H. Lehnert, and H. S. Randeva Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin Diabetes, September 1, 2009; 58(9): 1971 - 1977. [Abstract] [Full Text] [PDF]

				M. Lehrke, A. Becker, M. Greif, R. Stark, R. P Laubender, F. von Ziegler, C. Lebherz, J. Tittus, M. Reiser, C. Becker, et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis Eur. J. Endocrinol., August 1, 2009; 161(2): 339 - 344. [Abstract] [Full Text] [PDF]

				K. Bozaoglu, D. Segal, K. A. Shields, N. Cummings, J. E. Curran, A. G. Comuzzie, M. C. Mahaney, D. L. Rainwater, J. L. VandeBerg, J. W. MacCluer, et al. Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3085 - 3088. [Abstract] [Full Text] [PDF]

				A. Maheshwari, A. R. Kurundkar, S. S. Shaik, D. R. Kelly, Y. Hartman, W. Zhang, R. Dimmitt, S. Saeed, D. A. Randolph, C. Aprahamian, et al. Epithelial cells in fetal intestine produce chemerin to recruit macrophages Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G1 - G10. [Abstract] [Full Text] [PDF]

				A. Gonzalez-Periz, R. Horrillo, N. Ferre, K. Gronert, B. Dong, E. Moran-Salvador, E. Titos, M. Martinez-Clemente, M. Lopez-Parra, V. Arroyo, et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by {omega}-3 fatty acids: a role for resolvins and protectins FASEB J, June 1, 2009; 23(6): 1946 - 1957. [Abstract] [Full Text] [PDF]

				Y. Wu and C. M. Smas Wdnm1-like, a new adipokine with a role in MMP-2 activation Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E205 - E215. [Abstract] [Full Text] [PDF]